Physician profile
Teng C Lee
NPI 1235397142
$5,088.25
in general payments reported to CMS, 2019-2025
8 companies · $1,592 in 2025
The $1,592 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,458 · 2020: $118 · 2021: $7.01 · 2022: $295 · 2023: $512 · 2024: $1,107 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,670 · Food and Beverage: $1,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,669.87 |
| Food and Beverage | $1,540.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,632.63 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Artivion, INC. | $1,284.23 | 2025 | Amds-Ascyrus Medical, Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Medtronic Vascular, INC. | $1,123.35 | 2019 | |
| Abbott Laboratories | $453.05 | 2019-2024 | Navitor |
| W. L. Gore & Associates, INC. | $244.38 | 2019-2022 | |
| Bolton Medical INC | $193.25 | 2021-2022 | |
| Edwards Lifesciences Corporation | $142.88 | 2019-2025 | Mitris Resilia Mitral Valve |
| Kls-Martin L.P. | $14.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teng Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.